Vertex to Present at the J.P. Morgan Healthcare Conference on January 7
January 02 2019 - 4:01PM
Business Wire
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today
announced that management will present at the J.P. Morgan
Healthcare Conference on Monday, January 7, 2019 at 2:30 p.m. ET
(11:30 a.m. PT).
The audio portion of management’s remarks can be accessed live
through Vertex’s website, www.vrtx.com, in the “Investors” section
under the “News and Events” page. A replay of the conference
webcast will be archived on the company’s website.
About Vertex
Vertex is a global biotechnology company that invests in
scientific innovation to create transformative medicines for people
with serious and life-threatening diseases. In addition to clinical
development programs in CF, Vertex has more than a dozen ongoing
research programs focused on the underlying mechanisms of other
serious diseases.
Founded in 1989 in Cambridge, Mass., Vertex's headquarters is
now located in Boston's Innovation District. Today, the company has
research and development sites and commercial offices in the United
States, Europe, Canada, Australia and Latin America. Vertex is
consistently recognized as one of the industry's top places to
work, including being named to Science magazine's Top Employers in
the life sciences ranking for nine years in a row. For additional
information and the latest updates from the company, please visit
www.vrtx.com.
(VRTX-WEB)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190102005557/en/
Vertex Pharmaceuticals
IncorporatedInvestors:Michael Partridge,
617-341-6108Eric Rojas, 617-961-7205Zach Barber, 617-341-6470
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Apr 2023 to Apr 2024